Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Investigational New Drugs|August 5, 2004
Antiproliferative effects of ZD0473 (AMD473) in combination with 5-fluorouracil or SN38 in human colorectal cancer cell linesCarmen Plasencia, Albert Abad, Eva Martinez-Balibrea, et al.
Molecular Cancer Therapeutics|April 18, 2009
A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell linesEva Martinez-Balibrea, Carmen Plasencia, Alba Ginés, et al.
International Journal of Cancer|March 20, 2009
Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapyEva Martinez-Balibrea, Anna Martínez-Cardús, Eva Musulén, et al.
Journal of Medicinal Chemistry|February 18, 2005
Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug deliveryXiaoyuan Chen, Carmen Plasencia, Yingping Hou, et al.
Therapeutics and Clinical Risk Management|May 14, 2008
Reflections on adjuvant treatment of gastric cancerAlbert Abad, José Luis Manzano, Cristina Martí
Current Cancer Drug Targets|March 12, 2009
Elucidation of the molecular mechanisms of a salicylhydrazide class of compounds by proteomic analysisXuefei Cao, Carmen Plasencia, Atsuko Kanzaki, et al.
Biosensors & Bioelectronics|May 21, 2011
Design, development and application of a bioelectrochemical detection system for meat tenderness predictionKinga Zór, Marc Castellarnau, David Pascual, et al.
Cancer Metastasis Reviews|February 12, 2011
Innovations therapy: mammalian target of rapamycin (mTOR) inhibitors for the treatment of neuroendocrine tumorsJaume Capdevila, Ramón Salazar, Irene Halperín, et al.
The Journal of Liquid Biopsy|March 3, 2025
Liquid biopsy, big data and artificial intelligence as a new global clinical trial model in targeted therapyAlbert Abad, Joana Vidal, Laura Layos, et al.
Molecular Cancer Therapeutics|July 16, 2005
Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell linesCarmen Plasencia, Raveendra Dayam, Qingcai Wang, et al.
Pageof 4